Sign in
Not yet recruitingNo phase

Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea

Key facts

Who runs it
CHOSEOK YOON
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
100 people, planned
Started
15 Jun 2025
Expected to end
1 Feb 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Piperacillin/Tazobactam
  • Piperacillin/tazobactam + Levofloxacin
Record updated
18 May 2025

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Other criteria

  • Inclusion Criteria:; Adult patients aged 19 years or older who visited the emergency department and were hospitalized; Findings consistent with pneumonia diagnosis, meeting all of the following criteria:; Radiologic evidence of pulmonary infiltration on chest X-ray or chest CT; At least two or more of the following clinical signs:; Body temperature ≥38°C or <36°C ii) White blood cell count ≥11,000/µL or <4,000/µL iii) Presence of purulent sputum or bronchial secretions; Within 24 hours of admission, the patient meets one major criterion or three minor criteria according to ATS/IDSA classification:; Major criteria:; Invasive mechanical ventilation ii) Use of vasopressors (vasopressor-dependent septic shock); Minor criteria:; Respiratory rate ≥30 breaths/min ii) PaO2/FiO2 ≤ 250 iii) Multilobar infiltrates iv) Confusion or disorientation v) BUN ≥20 mg/dL vi) WBC <4,000/mm³ vii) Platelet count <100,000/mm³ viii) Hypothermia (temperature <36°C) ix) Hypotension requiring aggressive fluid resuscitation
  • Exclusion Criteria:; Transferred from another hospital after >48 hours of hospitalization; Died within 72 hours of hospital admission; Transferred to another hospital within 14 days of admission; Pneumonia occurring after >48 hours of mechanical ventilation, including home ventilators; Detection of influenza or SARS-CoV-2 virus within 7 days of hospitalization; Identified non-pneumonia infection requiring antibiotics within 72 hours of admission; Detection of piperacillin/tazobactam-resistant Enterobacterales, Pseudomonas spp., or Acinetobacter spp. in respiratory or blood cultures within the past 90 days; Antibiotic-related adverse events observed within 72 hours of assigned treatment, requiring discontinuation or change of antibiotics

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to provide high-level evidence for appropriate empirical antibiotic use tailored to the clinical reality in Korea by conducting a randomized controlled trial comparing monotherapy with piperacillin/tazobactam and combination therapy with piperacillin/tazobactam plus a fluoroquinolone in patients with severe community-acquired pneumonia.

The 2 groups in the trial

  • Piperacillin/Tazobactam MonotherapyTreatment being tested

    Patients receive empirical treatment with piperacillin/tazobactam alone for severe community-acquired pneumonia. The antibiotic is administered according to standard dosing guidelines for hospitalized patients.

    Treatment: Piperacillin/Tazobactam

  • Piperacillin/Tazobactam Plus Levofloxacin Combination TherapyExisting treatment, for comparison

    Patients receive empirical combination treatment with piperacillin/tazobactam and levofloxacin for severe community-acquired pneumonia. Both antibiotics are administered concurrently according to institutional protocols for combination therapy.

    Treatment: Piperacillin/tazobactam + Levofloxacin

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Verification of Anti-pseudomonal Antibiotic Combination Therapy in Severe Community-acquired Pneumonia in South Korea: A Randomized-controlled Study
Record updated
18 May 2025